Methylphenidate Rapid Test

COVID-19 抗原快速检测试剂盒包装正面
COVID-19 抗原快速检测试剂盒内容物
COVID-19 抗原快速检测试剂盒使用步骤示意图

Product Description

The Methylphenidate Rapid Test is a qualitative immunoassay designed for the rapid detection of methylphenidate in urine samples. This point-of-care test provides a quick and easy method for screening individuals for the presence of methylphenidate, a stimulant commonly prescribed for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The test utilizes a simple procedure with visually interpretable results, minimizing the need for specialized equipment or training. It aids in monitoring compliance with prescribed medication regimens, detecting potential misuse or abuse, and supporting clinical decision-making in relevant cases. The test is intended for use in clinical settings, such as doctor's offices, emergency rooms, and substance abuse treatment centers, where timely results are crucial.

Features

Specifications

Parameter Specification
Detection Target Methylphenidate
Sample Type Urine
Methodology Immunochromatographic assay
Detection Range Positive/Negative
Reaction Time 5-10 minutes
Storage Conditions 2-30°C
Shelf Life 18 months

Product Advantages

Early Screening Tool

Helps quickly identify infected individuals, implement timely isolation measures, and control the spread of the epidemic.

Suitable for Multiple Scenarios

Suitable for various scenarios such as home self-testing, corporate screening, schools, and clinics.

Reliable Quality

Strict quality control system ensures stable and reliable product performance.

Instructions for Use

  1. Read the instructions carefully.
  2. Prepare sample collection tools and the test kit.
  3. Collect the sample according to the instructions.
  4. Add the sample to the test cassette.
  5. Wait 15 minutes to read the results.

Certification Information

Interested in Methylphenidate Rapid Test?

Contact us for pricing, bulk orders, or any questions you may have.

Related Products